Signa Vitae

Print ISSN: 1334-5605 | Online ISSN: 1845-206X

Official journal of the International Women in Intensive and critical care Network (iWIN, https://www.iwinideal.com/home/)

Signa Vitae (SV) is a peer-reviewed, open-access journal whose Latin name means “Signs of Life.” It serves as an unbiased and permanent forum for Emergency Medicine, Intensive Care Medicine, Anesthesia and Pain Medicine, dedicated to the recognition, monitoring, intervention, nursing, and improvement of vital signs. The journal places particular emphasis on acute conditions requiring immediate intervention to stabilize vital signs, as well as various traumas and injuries; critical conditions; anesthetic techniques, pharmacological agents, monitoring, perioperative management and associated complications; and multimodal assessment and treatment of pain (with emphasis on acute/critical/perioperative pain, while also covering severe chronic pain).

The journal welcomes submissions of research closely related to the above fields, including risk factors, etiology, pathophysiology and molecular mechanisms of diseases, prognostic assessment and outcome improvement, disease management, healthcare professionals’ well-being (e.g., psychological stress, burnout, etc.), facilities and equipment, education and training (including simulation), and others—especially manuscripts with practical impact on patient vital sign stabilization, clinical practice, or medical care quality.

Editor-in-Chief

Prof. Giovanni Landoni, MD

Prof Giovanni Landoni, MD, is currently Full Professor and Residency Program Director of Anesthesia and Intensive Care Medicine at Vita-Salute San Raffaele University, Milan, Italy. He’s also Director of the Center for Intensive Care and Anesthesiology of San Raffaele Hospital in Milan, Italy. His strong clinical and research interests in intensive care and anesthesia resulted in more than 700 scientific publications in indexed journals, cited >20,000 times, h-index=75 on Scopus and 95 on Scholar, including randomized trials on NEJM, Lancet, and JAMA, and over 100 invitations in international congresses. He participated to 47 randomized controlled trials. Prof Landoni was Chief Investigator in successfully completed multicenter randomized clinical trials that randomized > 10,000 critically ill or perioperative patients over the last 10 years. He served as reviewer for over 50 journals (NEJM, JAMA, and The Lancet among others) and for foreign grant agencies, and he is member of the Editorial Board of several international journals.